Searching News Database: S Series
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 3 Mar 2026
Xsensio SA Raises $7M Oversubscribed Series A, Accelerates Clinical Deployment of Continuous Biosensing
Xsensio SA Raises $7M Oversubscribed Series A, Accelerates Clinical Deployment of Continuous Biosensing
HSMN NewsFeed - 24 Feb 2026
Brainomix Extends Series C Financing to $25.4M (£18.8M) to Support U.S. Expansion
Brainomix Extends Series C Financing to $25.4M (£18.8M) to Support U.S. Expansion
HSMN NewsFeed - 30 Jul 2025
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
HSMN NewsFeed - 25 Mar 2025
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
Hubble Therapeutics Closes Series A Financing to Develop Gene Therapy Cure for LCA16
HSMN NewsFeed - 6 Dec 2024
EQT Life Sciences Leads Series A Funding Round for Maternal Health Company Nua Surgical
EQT Life Sciences Leads Series A Funding Round for Maternal Health Company Nua Surgical
HSMN NewsFeed - 27 Jun 2024
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
HSMN NewsFeed - 9 Aug 2023
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease
HSMN NewsFeed - 3 Aug 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
HSMN NewsFeed - 21 Jul 2023
Hubly Surgical Raises $3 Million in Oversubscribed Funding Round Following FDA Clearance
Hubly Surgical Raises $3 Million in Oversubscribed Funding Round Following FDA Clearance
HSMN NewsFeed - 5 May 2023
Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO(TM) Green Pattern Laser
Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO(TM) Green Pattern Laser
HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
HSMN NewsFeed - 31 Aug 2022
iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
HSMN NewsFeed - 16 Aug 2022
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
HSMN NewsFeed - 17 May 2022
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
HSMN NewsFeed - 21 Apr 2022
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion
HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
HSMN NewsFeed - 30 Dec 2021
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
HSMN NewsFeed - 1 Dec 2021
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor
HSMN NewsFeed - 24 Nov 2021
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
HSMN NewsFeed - 2 Nov 2021
Argon Medical Launches Novel Innovations for Portal Vein Access Procedures
Argon Medical Launches Novel Innovations for Portal Vein Access Procedures
HSMN NewsFeed - 27 Jul 2021
MicroPort(R) Cardiac Rhythm Management Business Announces US$150 Million Series C Investment
MicroPort(R) Cardiac Rhythm Management Business Announces US$150 Million Series C Investment
HSMN NewsFeed - 8 Jul 2021
Theolytics expands Series A financing and welcomes M Ventures as a new investor
Theolytics expands Series A financing and welcomes M Ventures as a new investor
HSMN NewsFeed - 18 Jun 2021
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
Nuevocor closes US$24M Series A Financing to Advance Novel Gene Therapies for Cardiomyopathies
HSMN NewsFeed - 13 Apr 2021
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
HSMN NewsFeed - 19 Oct 2020
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
Solarea Bio Announces Series A Financing Led by S2G Ventures and Bold Capital Partners
HSMN NewsFeed - 23 Apr 2020
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
R2 Technologies Receives $10M Second Tranche Investment for Landmark CryoAesthetic Technology
HSMN NewsFeed - 24 Mar 2020
Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline
Apexigen Completes $123 Million Series C Financing To Advance Clinical Pipeline
HSMN NewsFeed - 9 Jan 2020
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
HSMN NewsFeed - 2 Jan 2020
CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs
CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs
HSMN NewsFeed - 17 Sep 2019
Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children
HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
HSMN NewsFeed - 13 May 2019
OMRON VENTURES Joins Theranica's Series B Funding Round as Strategic Investor
OMRON VENTURES Joins Theranica's Series B Funding Round as Strategic Investor
HSMN NewsFeed - 4 Apr 2019
Tioga Medical, A Shifamed Portfolio Company, Closes $15M In Series A Financing
Tioga Medical, A Shifamed Portfolio Company, Closes $15M In Series A Financing
HSMN NewsFeed - 15 May 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
HSMN NewsFeed - 30 Apr 2018
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough
HSMN NewsFeed - 26 Mar 2018
DarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
DarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
HSMN NewsFeed - 8 Jan 2018
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
HSMN NewsFeed - 7 Dec 2017
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
HSMN NewsFeed - 23 Aug 2017
Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures
Macrophage Pharma Limited Extends Series A Round to Include New Investor Merck Ventures
HSMN NewsFeed - 10 Aug 2017
NeoSync Secures $13 Million in Financing with Valiance Life Science Investments and Current Investors
NeoSync Secures $13 Million in Financing with Valiance Life Science Investments and Current Investors
HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
HSMN NewsFeed - 27 Jun 2017
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
HSMN NewsFeed - 23 May 2017
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
IFM Therapeutics Appoints H. Martin Seidel as Executive Vice President of Research and Development
HSMN NewsFeed - 8 May 2017
Lamellar Biomedical Raises £5.75 Million in Series C Fund Raising led by Invesco
Lamellar Biomedical Raises £5.75 Million in Series C Fund Raising led by Invesco
HSMN NewsFeed - 12 Apr 2017
Respira Therapeutics Announces Collaboration with United Therapeutics to Treat Pulmonary Hypertension
Respira Therapeutics Announces Collaboration with United Therapeutics to Treat Pulmonary Hypertension
HSMN NewsFeed - 22 Sep 2016
Kleo Pharmaceuticals Inc. Appoints David A. Spiegel as Chief Executive Officer
Kleo Pharmaceuticals Inc. Appoints David A. Spiegel as Chief Executive Officer
HSMN NewsFeed - 22 Sep 2016
Kleo Pharmaceuticals Inc. Appoints Roy Prieb as Chief Operating Officer and Chief Financial Officer
Kleo Pharmaceuticals Inc. Appoints Roy Prieb as Chief Operating Officer and Chief Financial Officer
HSMN NewsFeed - 15 Sep 2016
Eyevensys Announces Series A Extension Bringing Total Capital Raised to €9 Million
Eyevensys Announces Series A Extension Bringing Total Capital Raised to €9 Million
HSMN NewsFeed - 22 Jun 2016
Digital Health Company, Reflexion Health, Secures $18 Million for Its Series B Financing
Digital Health Company, Reflexion Health, Secures $18 Million for Its Series B Financing
HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
HSMN NewsFeed - 11 Jan 2016
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
HSMN NewsFeed - 17 Dec 2015
Xeltis Extends Series B Financing to €30M, Signing Off Transformational Year
Xeltis Extends Series B Financing to €30M, Signing Off Transformational Year
HSMN NewsFeed - 2 Dec 2015
Surefire Medical Closes $15M Series C Financing Led by Tullis Health Investors
Surefire Medical Closes $15M Series C Financing Led by Tullis Health Investors
HSMN NewsFeed - 28 Oct 2015
Turnstone Biologics Completes Series A Financing Led by Versant Ventures, Strengthens Management Team
Turnstone Biologics Completes Series A Financing Led by Versant Ventures, Strengthens Management Team
HSMN NewsFeed - 21 Oct 2015
Avita Medical Highlights ReCell(R) Findings Published in Journal of Cranio-Maxillo-Facial Surgery
Avita Medical Highlights ReCell(R) Findings Published in Journal of Cranio-Maxillo-Facial Surgery
HSMN NewsFeed - 2 Sep 2015
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
HSMN NewsFeed - 25 Jun 2015
Autonomic Technologies Completes Transatlantic Series D Financing of $43.2M
Autonomic Technologies Completes Transatlantic Series D Financing of $43.2M
HSMN NewsFeed - 6 Jan 2015
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
HSMN NewsFeed - 29 Oct 2014
Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug
Aileron Therapeutics Secures $33 Million in Series E Financing to Advance Its First-In-Class Cancer Drug
HSMN NewsFeed - 30 Jul 2014
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
HSMN NewsFeed - 22 May 2014
iRhythm Secures $17 Million in Funding Led by Novo A/S as Company Sees Record Growth for Its ZIO(R) Service
iRhythm Secures $17 Million in Funding Led by Novo A/S as Company Sees Record Growth for Its ZIO(R) Service
HSMN NewsFeed - 16 Apr 2014
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
HSMN NewsFeed - 3 Apr 2014
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
EMBL Ventures Invests £2M ($3.3M) in a Second Close of Crescendo Biologics' Series A Financing
HSMN NewsFeed - 6 Mar 2014
Edwards Lifesciences Announces First Human Implants With Mitral Transcatheter Valve System
Edwards Lifesciences Announces First Human Implants With Mitral Transcatheter Valve System
HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
HSMN NewsFeed - 5 Dec 2013
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
HSMN NewsFeed - 23 Sep 2013
Given Imaging Receives Clearance for the Third Generation PillCam(R) SB System in Japan
Given Imaging Receives Clearance for the Third Generation PillCam(R) SB System in Japan
HSMN NewsFeed - 30 Aug 2013
Jan Medical Announces Corporate Collaboration With, and Further Investment By, Brainlab
Jan Medical Announces Corporate Collaboration With, and Further Investment By, Brainlab
HSMN NewsFeed - 31 Jul 2013
Hansen Medical Enters Into Agreement With Investors to Receive up to $93 Million in Equity Financing
Hansen Medical Enters Into Agreement With Investors to Receive up to $93 Million in Equity Financing
HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
HSMN NewsFeed - 14 Jan 2013
Aileron Therapeutics Secures $12 Million for First-Ever Stapled Peptide Clinical Trial
Aileron Therapeutics Secures $12 Million for First-Ever Stapled Peptide Clinical Trial
HSMN NewsFeed - 27 Nov 2012
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
HSMN NewsFeed - 13 Nov 2012
Epic Sciences Announces Series B Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Epic Sciences Announces Series B Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
HSMN NewsFeed - 30 Oct 2012
Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds
HSMN NewsFeed - 20 Sep 2012
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
Third Rock Ventures Launches MyoKardia with $38 Million to Address Genetic Heart Disease
HSMN NewsFeed - 13 Jun 2012
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics
HSMN NewsFeed - 22 Feb 2012
Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
HSMN NewsFeed - 10 Aug 2011
UK's 1st Total Artificial Heart Patient Discharged Home Using Freedom(R) Portable Driver
UK's 1st Total Artificial Heart Patient Discharged Home Using Freedom(R) Portable Driver
HSMN NewsFeed - 1 Aug 2011
Beacon Endoscopic Ltd. Secures Series B Financing Through MVM Life Science Partners
Beacon Endoscopic Ltd. Secures Series B Financing Through MVM Life Science Partners
HSMN NewsFeed - 30 Jun 2011
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
HSMN NewsFeed - 11 May 2011
Seventh Sense Biosystems Secures $4.5 Million of Two-Tranche $10 Million Extension of its Series A Financing
Seventh Sense Biosystems Secures $4.5 Million of Two-Tranche $10 Million Extension of its Series A Financing
HSMN NewsFeed - 21 Mar 2011
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
HSMN NewsFeed - 8 Dec 2010
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
HSMN NewsFeed - 21 Oct 2010
Cerenis Therapeutics raises additional €10 million to close €50 million Series C financing
Cerenis Therapeutics raises additional €10 million to close €50 million Series C financing
HSMN NewsFeed - 6 Oct 2010
DiFUSION Technologies Receives 510(k) Clearance of Xiphos(TM) Interbody Implants for Spinal Fusion
DiFUSION Technologies Receives 510(k) Clearance of Xiphos(TM) Interbody Implants for Spinal Fusion
HSMN NewsFeed - 8 Sep 2010
Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients
HSMN NewsFeed - 22 Jul 2010
Integrated Diagnostics Secures $10 Million Second Tranche of Series A Financing
Integrated Diagnostics Secures $10 Million Second Tranche of Series A Financing
HSMN NewsFeed - 22 Jun 2010
David Nichols Joins Knee Creations, LLC. as Senior VP of Product Development & Operations
David Nichols Joins Knee Creations, LLC. as Senior VP of Product Development & Operations
HSMN NewsFeed - 26 May 2010
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
Alvine Pharmaceuticals Announces Equity Investment by Abbott Biotech Ventures Inc.
HSMN NewsFeed - 20 May 2010
NeuroTherapeutics Pharma Closes $43 Million Series B Financing and Adds Four New Investors
NeuroTherapeutics Pharma Closes $43 Million Series B Financing and Adds Four New Investors
HSMN NewsFeed - 27 Jan 2010
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
HSMN NewsFeed - 16 Dec 2009
Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
Savara Closes Second Tranche of Series A Financing Round, Receives Allowance for Base Patent
HSMN NewsFeed - 15 Dec 2009
CalciMedica Achieves Milestone and Draws Down Second Tranche of $12 Million Series C Financing
CalciMedica Achieves Milestone and Draws Down Second Tranche of $12 Million Series C Financing
HSMN NewsFeed - 5 Oct 2009
NeuroTherapeutics Pharma Appoints Dr. Corey Goodman to Its Board of Directors
NeuroTherapeutics Pharma Appoints Dr. Corey Goodman to Its Board of Directors
HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
HSMN NewsFeed - 2 Jun 2009
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
miRagen Therapeutics, Inc. Accomplishes Funding Milestones and Secures Series A Extension
HSMN NewsFeed - 20 May 2009
Pathway Medical Technologies Closes $42.5M Series D Financing; Announces New Investment From WRF Capital
Pathway Medical Technologies Closes $42.5M Series D Financing; Announces New Investment From WRF Capital
HSMN NewsFeed - 6 Apr 2009
Vasomedical Introduces BIOX Holter Monitoring Systems and Analysis Software
Vasomedical Introduces BIOX Holter Monitoring Systems and Analysis Software
HSMN NewsFeed - 17 Mar 2009
Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company
Cardiorobotics Announces New CEO, PLSG Executive-in-Residence to Lead Company
HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
HSMN NewsFeed - 17 Dec 2008
PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
HSMN NewsFeed - 1 Dec 2008
SonoSite Announces the New S-GYN™ A Specialized Ultrasound Tool for Gynecologists
SonoSite Announces the New S-GYN™ A Specialized Ultrasound Tool for Gynecologists
HSMN NewsFeed - 21 Nov 2008
SonoSite Awarded Portable Ultrasound Contract with HealthTrust Purchasing Group
SonoSite Awarded Portable Ultrasound Contract with HealthTrust Purchasing Group
HSMN NewsFeed - 20 Nov 2008
SonoSite Introduces S-FAST Vascular Access Option For Safer Emergent Procedures
SonoSite Introduces S-FAST Vascular Access Option For Safer Emergent Procedures
HSMN NewsFeed - 28 Oct 2008
Salient Surgical Technologies, Inc. Secures $17.9 Million in Series F Financing Round
Salient Surgical Technologies, Inc. Secures $17.9 Million in Series F Financing Round
HSMN NewsFeed - 29 Sep 2008
Oceana Therapeutics Commences Operations after Completing Series A Financing Round
Oceana Therapeutics Commences Operations after Completing Series A Financing Round
HSMN NewsFeed - 23 Sep 2008
Syneron(TM) Receives FDA Clearance for Versatile Matrix RF(TM) Fractional Ablative Applicator
Syneron(TM) Receives FDA Clearance for Versatile Matrix RF(TM) Fractional Ablative Applicator
HSMN NewsFeed - 19 Sep 2008
Syneron Receives European CE Mark for Versatile Matrix RF(TM) Fractional Ablative Applicator
Syneron Receives European CE Mark for Versatile Matrix RF(TM) Fractional Ablative Applicator
HSMN NewsFeed - 2 Sep 2008
Cardima Completes First Successful Cases in Thailand and Commences Training Program With Dr. Li Poa
Cardima Completes First Successful Cases in Thailand and Commences Training Program With Dr. Li Poa
HSMN NewsFeed - 11 Aug 2008
Xoft Secures $25 Million in Additional Funding for Award-Winning Electronic Brachytherapy Technology
Xoft Secures $25 Million in Additional Funding for Award-Winning Electronic Brachytherapy Technology
HSMN NewsFeed - 28 Jul 2008
Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
HSMN NewsFeed - 18 Jun 2008
Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
Cardiogenesis Announces Preliminary Results Combining TMR + Platelet Rich Plasma (PRP)
HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
HSMN NewsFeed - 9 May 2008
Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
Inverness Medical Innovations Completes Acquisition of Matria Healthcare, Inc.
HSMN NewsFeed - 17 Apr 2008
mtm laboratories Increases Series C Financing Round to Euro 31.6 Million (USD 50 Million)
mtm laboratories Increases Series C Financing Round to Euro 31.6 Million (USD 50 Million)
HSMN NewsFeed - 18 Mar 2008
LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round
LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round
HSMN NewsFeed - 17 Mar 2008
Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
HSMN NewsFeed - 10 Mar 2008
BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
HSMN NewsFeed - 26 Feb 2008
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
HSMN NewsFeed - 1 Feb 2008
James W. Richmond, Former Stryker Exec Joins Micronics' Board of Directors
James W. Richmond, Former Stryker Exec Joins Micronics' Board of Directors
HSMN NewsFeed - 21 Jan 2008
Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
HSMN NewsFeed - 20 Jan 2008
James LeVoy Sorenson, World-Renowned Medical Device Inventor, Entrepreneur and Philanthropist, Dies at 86
James LeVoy Sorenson, World-Renowned Medical Device Inventor, Entrepreneur and Philanthropist, Dies at 86
HSMN NewsFeed - 18 Dec 2007
Cardiac Dimensions(R) Inc. Announces Closing of $35.5 Million Round of Financing
Cardiac Dimensions(R) Inc. Announces Closing of $35.5 Million Round of Financing
HSMN NewsFeed - 18 Dec 2007
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics
HSMN NewsFeed - 17 Dec 2007
SonoSite Begins Customer Shipments of S Series Point-of-Care Ultrasound Tools
SonoSite Begins Customer Shipments of S Series Point-of-Care Ultrasound Tools
HSMN NewsFeed - 7 Dec 2007
Vidacare(R) Announces Clearance of Novel Bone Marrow Biopsy System for Hematology/Oncology
Vidacare(R) Announces Clearance of Novel Bone Marrow Biopsy System for Hematology/Oncology
HSMN NewsFeed - 15 Nov 2007
ConcepTx Medical Launched to Transform Compelling Medical Device Opportunities into New Businesses
ConcepTx Medical Launched to Transform Compelling Medical Device Opportunities into New Businesses
HSMN NewsFeed - 7 Nov 2007
Increased Adoption of Breakthrough Intraosseous Device Demonstrates Life-Saving Potential
Increased Adoption of Breakthrough Intraosseous Device Demonstrates Life-Saving Potential
HSMN NewsFeed - 6 Nov 2007
Sloning BioTechnology GmbH Raised EUR 4.7m in a First Closing of a Series E Equity Financing Round
Sloning BioTechnology GmbH Raised EUR 4.7m in a First Closing of a Series E Equity Financing Round
HSMN NewsFeed - 18 Oct 2007
Direct Flow Medical Raises $27 Million and Initiates European Clinical Trial
Direct Flow Medical Raises $27 Million and Initiates European Clinical Trial
HSMN NewsFeed - 2 Oct 2007
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer
Othera Pharmaceuticals Appoints Dr. Frederick R. Rickles Chief Scientific Officer
HSMN NewsFeed - 27 Sep 2007
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
Central Texas Health System Strengthens Processes for Contracting Through Premier's Breakthrough Series
HSMN NewsFeed - 13 Sep 2007
Aldagen Raises Additional $9 Million, Increasing Series C Financing to $23 Million
Aldagen Raises Additional $9 Million, Increasing Series C Financing to $23 Million
HSMN NewsFeed - 5 Sep 2007
Bar Harbor BioTechnology Inc. Completes Series A Financing for Product Launch
Bar Harbor BioTechnology Inc. Completes Series A Financing for Product Launch
HSMN NewsFeed - 13 Aug 2007
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
Ophthotech Raises $36 Million; In-Licenses Two Compounds for Macular Degeneration
HSMN NewsFeed - 11 Jun 2007
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
Intelect Medical Announces $7 Million Series B Investment from Boston Scientific and Greatbatch
HSMN NewsFeed - 30 May 2007
Vidacare(R) Announces Release of Novel Bone Marrow Aspiration System for Hematology/Oncology
Vidacare(R) Announces Release of Novel Bone Marrow Aspiration System for Hematology/Oncology
Additional items found! 85
Members Archive contains
85 additional stories matching:
S Series
(Password required)
S Series
(Password required)
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!